# Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115)

> **NCT01026870** · PHASE3 · WITHDRAWN · sponsor: **Organon and Co**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** SCH 32088 mometasone furoate (MF) metered-dose inhaler
- **DRUG:** Placebo metered-dose inhaler BID

## Key facts

- **NCT ID:** NCT01026870
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-06
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026870, "Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01026870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*